We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
Das, Sourav Sengupta, Soumik Pathak, Kangkan Sah, Divyashree Mehta, Sumit Avinash, Priya Ranjan Baruah, Aparajeeta Deuri, Sailendra Kumar Sarmah, Anil Gogoi, Vijay Kalita, Kamal Narayan and Hazarika, Jyoti 2018. Aggression as an independent entity even in psychosis – The role of cortisol. Psychiatry Research, Vol. 259, p. 405.
Nielsen, Mette Ødegaard Rostrup, Egill Broberg, Brian Villumsen Wulff, Sanne and Glenthøj, Birte 2018. Negative Symptoms and Reward Disturbances in Schizophrenia Before and After Antipsychotic Monotherapy. Clinical EEG and Neuroscience, Vol. 49, Issue. 1, p. 36.
Wood, Lisa and Irons, Chris 2017. Experienced stigma and its impacts in psychosis: The role of social rank and external shame. Psychology and Psychotherapy: Theory, Research and Practice, Vol. 90, Issue. 3, p. 419.
Lloyd, Helen Lloyd, Joanne Fitzpatrick, Ray and Peters, Michele 2017. The role of life context and self-defined well-being in the outcomes that matter to people with a diagnosis of schizophrenia. Health Expectations, Vol. 20, Issue. 5, p. 1061.
Lloyd, Joanne Lloyd, Helen Fitzpatrick, Ray and Peters, Michele 2017. Treatment outcomes in schizophrenia: qualitative study of the views of family carers. BMC Psychiatry, Vol. 17, Issue. 1,
Powers, John H. Patrick, Donald L. Walton, Marc K. Marquis, Patrick Cano, Stefan Hobart, Jeremy Isaac, Maria Vamvakas, Spiros Slagle, Ashley Molsen, Elizabeth and Burke, Laurie B. 2017. Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force. Value in Health, Vol. 20, Issue. 1, p. 2.
Vergunst, Francis Rugkåsa, Jorun Koshiaris, Constantinos Simon, Judit and Burns, Tom 2017. Community treatment orders and social outcomes for patients with psychosis: a 48-month follow-up study. Social Psychiatry and Psychiatric Epidemiology, Vol. 52, Issue. 11, p. 1375.
Vergunst, Francis Jenkinson, Crispin Burns, Tom Anand, Paul Gray, Alastair Rugkåsa, Jorun and Simon, Judit 2017. Psychometric validation of a multi-dimensional capability instrument for outcome measurement in mental health research (OxCAP-MH). Health and Quality of Life Outcomes, Vol. 15, Issue. 1,
Kim, Do-Won Lee, Seung-Hwan Shim, Miseon and Im, Chang-Hwan 2017. Estimation of Symptom Severity Scores for Patients with Schizophrenia Using ERP Source Activations during a Facial Affect Discrimination Task. Frontiers in Neuroscience, Vol. 11,
2017. Transdiagnostic Clinical Global Impression Scoring for Routine Clinical Settings. Behavioral Sciences, Vol. 7, Issue. 3, p. 40.
Egger, Stephan T. Vetter, Stefan Weniger, Godehard Vandeleur, Caroline Seifritz, Erich and Müller, Mario 2016. The Use of the Health of the Nation Outcome Scales for Assessing Functional Change in Treatment Outcome Monitoring of Patients with Chronic Schizophrenia. Frontiers in Public Health, Vol. 4,
Steibliene, Vesta Bunevicius, Adomas Savickas, Arunas Prange, Arthur J. Nemeroff, Charles B. and Bunevicius, Robertas 2016. Triiodothyronine accelerates and enhances the antipsychotic effect of risperidone in acute schizophrenia. Journal of Psychiatric Research, Vol. 73, p. 9.
Trousselard, M. Canini, F. Claverie, D. Cungi, C. Putois, B. and Franck, N. 2016. Cardiac Coherence Training to Reduce Anxiety in Remitted Schizophrenia, a Pilot Study. Applied Psychophysiology and Biofeedback, Vol. 41, Issue. 1, p. 61.
Priebe, Stefan Savill, Mark Wykes, Til Bentall, Richard Lauber, Christoph Reininghaus, Ulrich McCrone, Paul Mosweu, Iris Bremner, Stephen Eldridge, Sandra and Röhricht, Frank 2016. Clinical effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia: a multicentre randomised controlled trial. Health Technology Assessment, Vol. 20, Issue. 11, p. 1.
Xu, Dong (Roman) Gong, Wenjie Caine, Eric D Xiao, Shuiyuan Hughes, James P Ng, Marie Simoni, Jane He, Hua Smith, Kirk L Brown, Henry Shelton and Gloyd, Stephen 2016. Lay health supporters aided by a mobile phone messaging system to improve care of villagers with schizophrenia in Liuyang, China: protocol for a randomised control trial. BMJ Open, Vol. 6, Issue. 1, p. e010120.
Molina, Luis Recinos, Byron Paz, Bezner Rovelo, Mauricio Elias Rodriguez, Fanny Elizabeth Calderón, José Arellano, Arturo Pomata, Santiago Rey, María Verónica and Perez-Lloret, Santiago 2016. Factors Related to Early Clinical Effects of Quetiapine Extended-Release: A Multinational, Prospective, Observational Study. Clinical Drug Investigation, Vol. 36, Issue. 6, p. 491.
Asher, Laura De Silva, Mary Hanlon, Charlotte Weiss, Helen A. Birhane, Rahel Ejigu, Dawit A. Medhin, Girmay Patel, Vikram and Fekadu, Abebaw 2016. Community-based Rehabilitation Intervention for people with Schizophrenia in Ethiopia (RISE): study protocol for a cluster randomised controlled trial. Trials, Vol. 17, Issue. 1,
Taylor, Danielle L. Tiwari, Arun K. Lieberman, Jeffrey A. Potkin, Steven G. Meltzer, Herbert Y. Knight, Jo Remington, Gary Müller, Daniel J. and Kennedy, James L. 2016. Genetic association analysis of N-methyl-d-aspartate receptor subunit geneGRIN2Band clinical response to clozapine. Human Psychopharmacology: Clinical and Experimental, Vol. 31, Issue. 2, p. 121.
Das, Sourav Deuri, Sailendra Kumar Sarmah, Anil Pathak, Kangkan Baruah, Aparajeeta Sengupta, Soumik Mehta, Sumit Avinash, Priya Ranjan Kalita, Kamal Narayan and Hazarika, Jyoti 2016. Aggression as an independent entity even in psychosis- the role of inflammatory cytokines. Journal of Neuroimmunology, Vol. 292, p. 45.
Symptom rating scales are now well established in schizophrenia research buttheir scores are notthe same as outcome
To appraise the usefulness of symptom rating scales in evaluating the outcome of people with schizophrenia
Literature on the use of the Brief Psychiatric Rating Scale (BPRS) the Positive and Negative Syndrome Scale (PANSS) and the Clinical Global Impression (CGI) in schizophrenia research was studied
Scales were designed to make diagnoses, to categorise patients, syndromes or both, and to demonstrate antipsychotic efficacy, as well as to measure outcome. There is much redundancy both between and within scales. Early work suggests limited concurrent validity with external outcome variables. Data are at best ordinal and there are particular difficulties in equating outcome with percentage changes in scores. The concept of remission, which uses absolute item score thresholds with a duration criterion, is a promising outcome measure
Symptom rating scale scores can only comprise a limited part of outcome measurement. Standardised remission criteria may present advantages in outcome research
To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.
Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Find out more about the Kindle Personal Document Service.
To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.
To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.
* Views captured on Cambridge Core between 2nd January 2018 - 21st April 2018. This data will be updated every 24 hours.
Das, Sourav Sengupta, Soumik Pathak, Kangkan Sah, Divyashree Mehta, Sumit Avinash, Priya Ranjan Baruah, Aparajeeta Deuri, Sailendra Kumar Sarmah, Anil Gogoi, Vijay Kalita, Kamal Narayan and Hazarika, Jyoti 2018. Aggression as an independent entity even in psychosis – The role of cortisol. Psychiatry Research, Vol. 259, p. 405.
Nielsen, Mette Ødegaard Rostrup, Egill Broberg, Brian Villumsen Wulff, Sanne and Glenthøj, Birte 2018. Negative Symptoms and Reward Disturbances in Schizophrenia Before and After Antipsychotic Monotherapy. Clinical EEG and Neuroscience, Vol. 49, Issue. 1, p. 36.
Wood, Lisa and Irons, Chris 2017. Experienced stigma and its impacts in psychosis: The role of social rank and external shame. Psychology and Psychotherapy: Theory, Research and Practice, Vol. 90, Issue. 3, p. 419.
Lloyd, Helen Lloyd, Joanne Fitzpatrick, Ray and Peters, Michele 2017. The role of life context and self-defined well-being in the outcomes that matter to people with a diagnosis of schizophrenia. Health Expectations, Vol. 20, Issue. 5, p. 1061.
Lloyd, Joanne Lloyd, Helen Fitzpatrick, Ray and Peters, Michele 2017. Treatment outcomes in schizophrenia: qualitative study of the views of family carers. BMC Psychiatry, Vol. 17, Issue. 1,
Powers, John H. Patrick, Donald L. Walton, Marc K. Marquis, Patrick Cano, Stefan Hobart, Jeremy Isaac, Maria Vamvakas, Spiros Slagle, Ashley Molsen, Elizabeth and Burke, Laurie B. 2017. Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force. Value in Health, Vol. 20, Issue. 1, p. 2.
Vergunst, Francis Rugkåsa, Jorun Koshiaris, Constantinos Simon, Judit and Burns, Tom 2017. Community treatment orders and social outcomes for patients with psychosis: a 48-month follow-up study. Social Psychiatry and Psychiatric Epidemiology, Vol. 52, Issue. 11, p. 1375.
Vergunst, Francis Jenkinson, Crispin Burns, Tom Anand, Paul Gray, Alastair Rugkåsa, Jorun and Simon, Judit 2017. Psychometric validation of a multi-dimensional capability instrument for outcome measurement in mental health research (OxCAP-MH). Health and Quality of Life Outcomes, Vol. 15, Issue. 1,
Kim, Do-Won Lee, Seung-Hwan Shim, Miseon and Im, Chang-Hwan 2017. Estimation of Symptom Severity Scores for Patients with Schizophrenia Using ERP Source Activations during a Facial Affect Discrimination Task. Frontiers in Neuroscience, Vol. 11,
2017. Transdiagnostic Clinical Global Impression Scoring for Routine Clinical Settings. Behavioral Sciences, Vol. 7, Issue. 3, p. 40.
Egger, Stephan T. Vetter, Stefan Weniger, Godehard Vandeleur, Caroline Seifritz, Erich and Müller, Mario 2016. The Use of the Health of the Nation Outcome Scales for Assessing Functional Change in Treatment Outcome Monitoring of Patients with Chronic Schizophrenia. Frontiers in Public Health, Vol. 4,
Steibliene, Vesta Bunevicius, Adomas Savickas, Arunas Prange, Arthur J. Nemeroff, Charles B. and Bunevicius, Robertas 2016. Triiodothyronine accelerates and enhances the antipsychotic effect of risperidone in acute schizophrenia. Journal of Psychiatric Research, Vol. 73, p. 9.
Trousselard, M. Canini, F. Claverie, D. Cungi, C. Putois, B. and Franck, N. 2016. Cardiac Coherence Training to Reduce Anxiety in Remitted Schizophrenia, a Pilot Study. Applied Psychophysiology and Biofeedback, Vol. 41, Issue. 1, p. 61.
Priebe, Stefan Savill, Mark Wykes, Til Bentall, Richard Lauber, Christoph Reininghaus, Ulrich McCrone, Paul Mosweu, Iris Bremner, Stephen Eldridge, Sandra and Röhricht, Frank 2016. Clinical effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia: a multicentre randomised controlled trial. Health Technology Assessment, Vol. 20, Issue. 11, p. 1.
Xu, Dong (Roman) Gong, Wenjie Caine, Eric D Xiao, Shuiyuan Hughes, James P Ng, Marie Simoni, Jane He, Hua Smith, Kirk L Brown, Henry Shelton and Gloyd, Stephen 2016. Lay health supporters aided by a mobile phone messaging system to improve care of villagers with schizophrenia in Liuyang, China: protocol for a randomised control trial. BMJ Open, Vol. 6, Issue. 1, p. e010120.
Molina, Luis Recinos, Byron Paz, Bezner Rovelo, Mauricio Elias Rodriguez, Fanny Elizabeth Calderón, José Arellano, Arturo Pomata, Santiago Rey, María Verónica and Perez-Lloret, Santiago 2016. Factors Related to Early Clinical Effects of Quetiapine Extended-Release: A Multinational, Prospective, Observational Study. Clinical Drug Investigation, Vol. 36, Issue. 6, p. 491.
Asher, Laura De Silva, Mary Hanlon, Charlotte Weiss, Helen A. Birhane, Rahel Ejigu, Dawit A. Medhin, Girmay Patel, Vikram and Fekadu, Abebaw 2016. Community-based Rehabilitation Intervention for people with Schizophrenia in Ethiopia (RISE): study protocol for a cluster randomised controlled trial. Trials, Vol. 17, Issue. 1,
Taylor, Danielle L. Tiwari, Arun K. Lieberman, Jeffrey A. Potkin, Steven G. Meltzer, Herbert Y. Knight, Jo Remington, Gary Müller, Daniel J. and Kennedy, James L. 2016. Genetic association analysis of N-methyl-d-aspartate receptor subunit geneGRIN2Band clinical response to clozapine. Human Psychopharmacology: Clinical and Experimental, Vol. 31, Issue. 2, p. 121.
Das, Sourav Deuri, Sailendra Kumar Sarmah, Anil Pathak, Kangkan Baruah, Aparajeeta Sengupta, Soumik Mehta, Sumit Avinash, Priya Ranjan Kalita, Kamal Narayan and Hazarika, Jyoti 2016. Aggression as an independent entity even in psychosis- the role of inflammatory cytokines. Journal of Neuroimmunology, Vol. 292, p. 45.
Symptom rating scales and outcome in schizophrenia
eLetters
No eLetters have been published for this article.